IBDEI0RL ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13626,2)
 ;;=^269591
 ;;^UTILITY(U,$J,358.3,13627,0)
 ;;=796.2^^90^848^30
 ;;^UTILITY(U,$J,358.3,13627,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13627,1,4,0)
 ;;=4^796.2
 ;;^UTILITY(U,$J,358.3,13627,1,5,0)
 ;;=5^Elev BP w/o dx hypertension
 ;;^UTILITY(U,$J,358.3,13627,2)
 ;;=^273464
 ;;^UTILITY(U,$J,358.3,13628,0)
 ;;=402.10^^90^848^31
 ;;^UTILITY(U,$J,358.3,13628,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13628,1,4,0)
 ;;=4^402.10
 ;;^UTILITY(U,$J,358.3,13628,1,5,0)
 ;;=5^HTN w/ Heart Involvement
 ;;^UTILITY(U,$J,358.3,13628,2)
 ;;=^269598
 ;;^UTILITY(U,$J,358.3,13629,0)
 ;;=402.11^^90^848^32
 ;;^UTILITY(U,$J,358.3,13629,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13629,1,4,0)
 ;;=4^402.11
 ;;^UTILITY(U,$J,358.3,13629,1,5,0)
 ;;=5^HTN with CHF
 ;;^UTILITY(U,$J,358.3,13629,2)
 ;;=HTN with CHF^269599
 ;;^UTILITY(U,$J,358.3,13630,0)
 ;;=403.11^^90^848^37
 ;;^UTILITY(U,$J,358.3,13630,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13630,1,4,0)
 ;;=4^403.11
 ;;^UTILITY(U,$J,358.3,13630,1,5,0)
 ;;=5^HTN with Renal Failure
 ;;^UTILITY(U,$J,358.3,13630,2)
 ;;=^269608
 ;;^UTILITY(U,$J,358.3,13631,0)
 ;;=404.10^^90^848^35
 ;;^UTILITY(U,$J,358.3,13631,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13631,1,4,0)
 ;;=4^404.10
 ;;^UTILITY(U,$J,358.3,13631,1,5,0)
 ;;=5^HTN with Heart & Renal Involvement
 ;;^UTILITY(U,$J,358.3,13631,2)
 ;;=^269618
 ;;^UTILITY(U,$J,358.3,13632,0)
 ;;=404.11^^90^848^33
 ;;^UTILITY(U,$J,358.3,13632,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13632,1,4,0)
 ;;=4^404.11
 ;;^UTILITY(U,$J,358.3,13632,1,5,0)
 ;;=5^HTN with CHF & Renal Involvement
 ;;^UTILITY(U,$J,358.3,13632,2)
 ;;=^269619
 ;;^UTILITY(U,$J,358.3,13633,0)
 ;;=404.12^^90^848^36
 ;;^UTILITY(U,$J,358.3,13633,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13633,1,4,0)
 ;;=4^404.12
 ;;^UTILITY(U,$J,358.3,13633,1,5,0)
 ;;=5^HTN with Heart Involvement & Renal Failure
 ;;^UTILITY(U,$J,358.3,13633,2)
 ;;=^269620
 ;;^UTILITY(U,$J,358.3,13634,0)
 ;;=404.13^^90^848^34
 ;;^UTILITY(U,$J,358.3,13634,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13634,1,4,0)
 ;;=4^404.13
 ;;^UTILITY(U,$J,358.3,13634,1,5,0)
 ;;=5^HTN with CHF & Renal failure
 ;;^UTILITY(U,$J,358.3,13634,2)
 ;;=^269621
 ;;^UTILITY(U,$J,358.3,13635,0)
 ;;=401.9^^90^848^57
 ;;^UTILITY(U,$J,358.3,13635,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13635,1,4,0)
 ;;=4^401.9
 ;;^UTILITY(U,$J,358.3,13635,1,5,0)
 ;;=5^Hypertension, Essential
 ;;^UTILITY(U,$J,358.3,13635,2)
 ;;=^186630
 ;;^UTILITY(U,$J,358.3,13636,0)
 ;;=272.0^^90^848^55
 ;;^UTILITY(U,$J,358.3,13636,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13636,1,4,0)
 ;;=4^272.0
 ;;^UTILITY(U,$J,358.3,13636,1,5,0)
 ;;=5^Hypercholesterolemia, Pure
 ;;^UTILITY(U,$J,358.3,13636,2)
 ;;=^59973
 ;;^UTILITY(U,$J,358.3,13637,0)
 ;;=272.1^^90^848^58
 ;;^UTILITY(U,$J,358.3,13637,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13637,1,4,0)
 ;;=4^272.1
 ;;^UTILITY(U,$J,358.3,13637,1,5,0)
 ;;=5^Hypertriglyceridemia
 ;;^UTILITY(U,$J,358.3,13637,2)
 ;;=Hypertriglyceridemia^101303
 ;;^UTILITY(U,$J,358.3,13638,0)
 ;;=272.2^^90^848^63
 ;;^UTILITY(U,$J,358.3,13638,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13638,1,4,0)
 ;;=4^272.2
 ;;^UTILITY(U,$J,358.3,13638,1,5,0)
 ;;=5^Mixed Hyperlipidemia
 ;;^UTILITY(U,$J,358.3,13638,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,13639,0)
 ;;=396.0^^90^848^11
 ;;^UTILITY(U,$J,358.3,13639,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13639,1,4,0)
 ;;=4^396.0
 ;;^UTILITY(U,$J,358.3,13639,1,5,0)
 ;;=5^Aortic and Mitral Stenosis
 ;;^UTILITY(U,$J,358.3,13639,2)
 ;;=Aortic and Mitral Stenosis^269580
